The latest on Methuselah, health span research, and regenerative medicine
On a recent trip to California, my goal was to document an aircraft’s actual interior cabin altitude, versus the altitude of that aircraft’s distance above the ground. Finding this altitude would tell me how much oxygen would be in the cabin, where lower altitudes would mean more available oxygen.
Read MoreWe modestly present a journey into our personal experience with "near field environmental factors" and health. This series will be the first entry in what we hope will become a shared resource that helps us all get better and better. Welcome to N of One!
Read MoreThe elderly have wisdom of great value to all, but few listen. Their story is worth being heard. If things don’t change, we will all share their experience. This first-person narrative is the result of years of interviews and the extensive experience of a Registered Nurse specializing in Geriatrics. We invite you to live a day in the live of a 90 year old.
Read MoreWhat defines an average 90-year-old scientifically?
What defines a 50-year-old?
How could we make 90 the new 50 by 2030?
The Methuselah Fund or M Fund is mission-oriented and was conceived after successful angel investments by the Methuselah Foundation. The M Fund's investment thesis is based on six strategies aimed at increasing healthy longevity and its current portfolio includes four exciting companies.
Read MoreFor a while, we have seen that anti-aging is rapidly becoming an engineering challenge rather than a mere fantasy. To this point, our Foundation is also working on helping create a professional society focused on Geroengineering. Enter, the Society of Gero-Engineering and Technology, or SGET.
Read MoreOur friends at LEAF took the time to ask some interesting questions to our CEO and longevity community pioneer, David Gobel. We hope you enjoy his answers to these great questions.
Read MoreHere is a fun question... Can you name one hole in your body that, if sewn shut, would help you function better?
Assuming you have an anatomically normal body, the answer is none. While saying that "bad plumbing" causes Alzheimer's Disease is an oversimplification, it is a great way to quickly explain why we angel invested in Leucadia Therapeutics in 2015. The Principal Scientist, Founder, and CEO of Leucadia Therapeutics, Doug Ethell, Ph.D., had an Occam Razor's approach to AD, which was refreshing to us and an inspiration. As it turns out, the Cribriform Plate that drains cerebrospinal fluid can get ossified or clogged as you age. In AD patients, it is always significantly clogged, thus the "bad plumbing" analogy.
In light of the underwhelming efficacy of human anti-Abeta clinical trials in the last several years, we are pleased to read the scientific community starting to reconsider the theory that amyloid beta (Abeta) is the primary causative factor in Alzheimer's disease. This paper is among several we've seen over the past year which criticizes the amyloid cascade hypothesis, and does a good job of balancing the supportive and contradictory evidence for the hypothesis.
Read MoreIt is well known that one of Methuselah Foundation's initiative is the New Organ Alliance. The following is the latest update on the progress this venture is having. Enjoy!
Read MoreWhat's new at Methuselah Foundation? What recent scientific data has you excited about the future of this field? What should I do in order to be a healthier longer live? These are questions we received on an on-going basis. That is why we've decided to change our blog in a way that adds value to our community. We will mainly act as an aggregator of media, with some original pieces sprinkled in between. We hope that this new format will have you coming back for more content!
Read More
